Åke Gunnar Wikström

Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Founded in 1952, Part of Mundipharma IT Services GmbH, Mundipharma IT Services Ltd. provides information technology services. The company is based in Cambridge, UK.

Founded in 1952, Part of Mundipharma IT Services GmbH, Mundipharma IT Services Ltd. provides information technology services. The company is based in Cambridge, UK.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany

Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany

Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany

Napp Pharmaceuticals Ltd. manufactures and wholesales pharmaceutical products. It offers analgesic, oncology and respiratory products and provides oral, transdermal, and parenteral delivery of products. The company was founded in 1923 and is headquartered in Cambridge, the United Kingdom.

Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom.

Mundipharma GmbH is one of the leading mid-sized pharmaceutical companies in Germany, has specialized successfully in the treatment of pain. Additional areas of research-based company are the areas of oncology and respiratory. The positive performance is reflected very clearly reflected in revenue and company size. The company was founded in 1967 and is headquartered in Limburg an der Lahn, Germany